What was the valuation of the UK nanomedicine market in 2024?

The valuation of the UK nanomedicine market was $12.32 Billion in 2024. Read More

What is the projected market valuation for the UK nanomedicine market by 2035?

The projected market valuation for the UK nanomedicine market is $44.99 Billion by 2035. Read More

What is the expected CAGR for the UK nanomedicine market during the forecast period 2025 - 2035?

The expected CAGR for the UK nanomedicine market during the forecast period 2025 - 2035 is 12.5%. Read More

Which companies are considered key players in the UK nanomedicine market?

Key players in the UK nanomedicine market include Amgen Inc, Bristol-Myers Squibb Company, Johnson & Johnson, Roche Holding AG, Novartis AG, Pfizer Inc, Merck & Co Inc, Sanofi, and AstraZeneca PLC. Read More

What are the main application segments of the UK nanomedicine market?

The main application segments of the UK nanomedicine market include Drug Delivery, Diagnostic Imaging, Therapeutic Applications, and Regenerative Medicine. Read More

What was the market size for Drug Delivery in the UK nanomedicine market in 2024?

The market size for Drug Delivery in the UK nanomedicine market was $3.7 Billion in 2024. Read More

What is the projected market size for Therapeutic Applications by 2035?

The projected market size for Therapeutic Applications in the UK nanomedicine market is $15.0 Billion by 2035. Read More

What types of nanoparticles are included in the UK nanomedicine market?

The types of nanoparticles in the UK nanomedicine market include Nanoparticles, Nanoshells, Nanorobots, and Nanocapsules. Read More

What was the market size for Nanocarriers in the UK nanomedicine market in 2024?

The market size for Nanocarriers in the UK nanomedicine market was $2.46 Billion in 2024. Read More

What is the projected market size for Nanodiagnostics by 2035?

The projected market size for Nanodiagnostics in the UK nanomedicine market is $8.94 Billion by 2035. Read More

UK Nanomedicine Market

UK Nanomedicine Market Research Report: Size, Share, Trend Analysis By Applications (Drug Delivery, Diagnostic Imaging, Therapeutic Applications, Regenerative Medicine), By Types (Nanoparticles, Nanoshells, Nanorobots, Nanocapsules), By End Use (Pharmaceuticals, Biotechnology, Healthcare, Research Laboratories) andBy Technology (Targeted Drug Delivery, Nanocarriers, Nanotherapeutics, Nanodiagnostics) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

12.5%

2024 Market Size

$ 12.32 Billion

2035 Market Size

$ 44.99 Billion

Healthcare ● Updated August 2026 Report ID: MRFR/HC/51702-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Application (USD Billion)
  1. 4.1.1 Drug Delivery
  2. 4.1.2 Diagnostic Imaging
  3. 4.1.3 Therapeutic Applications
  4. 4.1.4 Regenerative Medicine
2. 4.2 Security, Access Control and Robotics, BY Type (USD Billion)
  1. 4.2.1 Nanoparticles
  2. 4.2.2 Nanoshells
  3. 4.2.3 Nanorobots
  4. 4.2.4 Nanocapsules
3. 4.3 Security, Access Control and Robotics, BY End-use (USD Billion)
  1. 4.3.1 Pharmaceuticals
  2. 4.3.2 Biotechnology
  3. 4.3.3 Healthcare
  4. 4.3.4 Research Laboratories
4. 4.4 Security, Access Control and Robotics, BY Technology (USD Billion)
  1. 4.4.1 Targeted Drug Delivery
  2. 4.4.2 Nanocarriers
  3. 4.4.3 Nanotherapeutics
  4. 4.4.4 Nanodiagnostics
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Amgen Inc (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bristol-Myers Squibb Company (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Roche Holding AG (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Novartis AG (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Pfizer Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Merck & Co Inc (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 AstraZeneca PLC (GB)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY TYPE
4. 6.4 UK MARKET ANALYSIS BY END-USE
5. 6.5 UK MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
9. 6.9 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
12. 6.12 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 (% SHARE)
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 (% SHARE)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USE, 2024 (% SHARE)
17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY END-USE, 2024 TO 2035 (USD Billion)
18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  2. 7.2.2 BY TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Nanomedicine Market Segmentation

UK Nanomedicine Market By Application (USD Billion, 2025-2035)

Drug Delivery
Diagnostic Imaging
Therapeutic Applications
Regenerative Medicine

UK Nanomedicine Market By Type (USD Billion, 2025-2035)

Nanoparticles
Nanoshells
Nanorobots
Nanocapsules

UK Nanomedicine Market By End-use (USD Billion, 2025-2035)

Pharmaceuticals
Biotechnology
UK Nanomedicine Market
Research Laboratories

UK Nanomedicine Market By Technology (USD Billion, 2025-2035)

Targeted Drug Delivery
Nanocarriers
Nanotherapeutics
Nanodiagnostics

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”